PHARMACOTHERAPY AND DRUG SAFETY
Publications (276) Publications in which a researcher has participated
2024
-
A comparison of dermal toxicity models; assessing suitability for safe(r)-by-design decision-making and for screening nanomaterial hazards
Toxicology in Vitro, Vol. 97
-
Acetazolamide-induced pulmonary oedema: A disproportionality analysis from the EudraVigilance database
British Journal of Clinical Pharmacology, Vol. 90, Núm. 7, pp. 1751-1755
-
Analysis 2016-2021 of the development of the MAPEX outpatient pharmaceutical care Project by regions in Spain
Farmacia Hospitalaria, Vol. 48, Núm. 2, pp. 64-69
-
Analysis of the evolution of outpatient pharmaceutical care in hospital pharmacy services in Spain after the implementation and development of the MAPEX initiative
Journal of Healthcare Quality Research, Vol. 39, Núm. 2, pp. 65-79
-
Analysis of the situation of pharmaceutical care for patients with immune-mediated inflammatory diseases before and after the COVID-19 pandemic
Farmacia Hospitalaria
-
Assessing the Toxicity of Metal- and Carbon-Based Nanomaterials In Vitro: Impact on Respiratory, Intestinal, Skin, and Immune Cell Lines
International Journal of Molecular Sciences, Vol. 25, Núm. 20
-
Biosimilars and access to biologic therapy in immune-mediated diseases
Expert Opinion on Biological Therapy, Vol. 24, Núm. 7, pp. 647-653
-
Drug-induced hyponatraemia and possible related signals: Analysis of 659 cases reported to the Spanish Pharmacovigilance System and disproportionality analysis
Medicina Clinica
-
Eduardo Areitio Cebrecos: en el recuerdo
Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 121, Núm. 2, pp. 99-100
-
Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta
Biomedicine and Pharmacotherapy, Vol. 175
-
Improving the dichloro-dihydro-fluorescein (DCFH) assay for the assessment of intracellular reactive oxygen species formation by nanomaterials
NanoImpact, Vol. 35
-
Incorporating the One Health philosophy into pharmacovigilanc: Pharmacovigilance
British Journal of Clinical Pharmacology
-
Intranasal esketamine and manic symptoms: A disproportionality analysis in EudraVigilance
European Neuropsychopharmacology
-
Next Generation Risk Assessment approaches for advanced nanomaterials: Current status and future perspectives
NanoImpact, Vol. 35
-
Psychometric characteristics of the Spanish version of the HIV Symptom Index
Journal of patient-reported outcomes, Vol. 8, Núm. 1, pp. 116
-
[Translated article] Analysis 2016-2021 of the development of the MAPEX outpatient pharmaceutical care Project by Regions in Spain
Farmacia Hospitalaria, Vol. 48, Núm. 2, pp. T64-T69
-
[Translated article] Pharmaceuticals in the environment: A hospital pharmacy perspective
Farmacia Hospitalaria, Vol. 48, pp. TS13-TS20
2023
-
Analysis of heat stroke and heat exhaustion cases in EudraVigilance pharmacovigilance database
European Journal of Clinical Pharmacology, Vol. 79, Núm. 5, pp. 679-685
-
Comparación de múltiples redes neuronales convolucionales para el diagnóstico automático de la degeneración macular asociada a la edad usando retinografías
CASEIB 2023. Libro de Actas del XLI Congreso Anual de la Sociedad Española de Ingeniería Biomédica: Contribuyendo a la salud basada en valor
-
Hypersensitivity reactions associated with iron isomaltoside and ferric carboxymaltose
European Journal of Internal Medicine